017sek
-1,3 %
Date:2025-07-30Time:12:04:30Latest report:Q1-2025List:First NorthTicker:SPEC
Market Cap:68 msekEnterprise Value:65 msekNet Sales:- msekEarnings:-23,3 msekEmployees:0ISIN:SE0007158118

Ratios

10-year key figure history for SpectraCure turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for SpectraCure with index and moving average MA50 and MA200.

Stockprice:0,17
MA50:0,34
MA200:1,52
Price/MA200:-89,0 %
RSI (14):39,0
Price/MA50:-50,9 %

Description

SpectraCure operates in the medical technology sector. The company specializes in research and development of medical technology systems used for the treatment of prostate cancer. The cancer treatments are based on proprietary systems that emit laser light sources and photoreactive drugs, a treatment methodology used for internal solid tumors of various types. The largest operations are found in the Nordic market. The company has its headquarters in Lund.

Medical Equipment